L-deprenyl, a MAO-B inhibitor, as an adjunct to conventional L-dopa therapy in Parkinson's disease: experience in 200 patients.

T. S. Elizan, M. D. Yahr, D. A. Moros, M. R. Mendoza, S. Pang, C. A. Bodian

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Cite this

@article{34a5243665db40b08ced713e1edc0474,

title = "L-deprenyl, a MAO-B inhibitor, as an adjunct to conventional L-dopa therapy in Parkinson's disease: experience in 200 patients.",

author = "Elizan, {T. S.} and Yahr, {M. D.} and Moros, {D. A.} and Mendoza, {M. R.} and S. Pang and Bodian, {C. A.}",

year = "1990",

language = "English",

volume = "53",

pages = "431--435",

journal = "Advances in neurology",

issn = "0091-3952",

publisher = "Raven Press",

}

TY - JOUR

T1 - L-deprenyl, a MAO-B inhibitor, as an adjunct to conventional L-dopa therapy in Parkinson's disease

T2 - experience in 200 patients.

AU - Elizan, T. S.

AU - Yahr, M. D.

AU - Moros, D. A.

AU - Mendoza, M. R.

AU - Pang, S.

AU - Bodian, C. A.

PY - 1990

Y1 - 1990

UR - http://www.scopus.com/inward/record.url?scp=0025028144&partnerID=8YFLogxK

M3 - Article

C2 - 2122649

AN - SCOPUS:0025028144

SN - 0091-3952

VL - 53

SP - 431

EP - 435

JO - Advances in neurology

JF - Advances in neurology

ER -